Halia Therapeutics to Participate in Jefferies 2026 Global Healthcare Conference

LEHI, Utah, May 28, 2026 /PRNewswire/ -- Halia Therapeutics, Inc., The Genetic Resilience Company™, a clinical-stage biopharmaceutical company advancing first-in-class inflammation therapies anchored in protective human genetics, today announced that the Company will participate in the...